I Led Harvard’s Medical School, and I Fear for What’s to Come
Dr. Jeffrey Flier is an endocrinologist and a professor at Harvard Medical School, where he was the dean from 2007 to 2016.
‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS)
Hims & Hers Health (HIMS) is trying its best to stay relevant in the multi-billion dollar obesity treatment market. Despite a ...
New Carrington College leader eyes Sacramento expansion of health care education programs
Carrington College has named Nick Gomez as its new president, with a focus on expanding the college's footprint in Sacramento ...
Why Hims & Hers Health Stock Couldn't Beat the Market Today
Hims & Hers Health ( HIMS 0.37%) stock labored mightily on Wednesday, but in the end, it couldn't top the benchmark S&P 500 index. Investor excitement about news of a fresh product launch the previous ...
Investor's Business Daily on MSN3d
Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch
Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers' branded tirzepatide.